Back
Teva Pharmaceutical Industries Vs. Can Fite Biofarma Industry Stock Comparison
Buy
65
TEVA
Teva Pharmaceutical Industries
Last Price:
$22.09
Seasonality Move:
6.8%
Sell
16
CANF
Can Fite Biofarma
Last Price:
$1.48
Seasonality Move:
-5.63%
Buy
65
Teva Pharmaceutical Industries (TEVA)
is a Buy
Is Teva Pharmaceutical Industries a Buy, Sell or Hold?
-
The current Teva Pharmaceutical Industries [TEVA] share price is $22.09. The Score for TEVA is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
-
TEVA is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
16
Can Fite Biofarma (CANF)
is a Sell
Is Can Fite Biofarma a Buy, Sell or Hold?
-
The current Can Fite Biofarma [CANF] share price is $1.48. The Score for CANF is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
-
CANF is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
TEVA Stock Price Chart
What is Teva Pharmaceutical Industries's stock price today?
-
The Teva Pharmaceutical Industries share price today is $22.09Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TEVA is experiencing buying pressure, which is a positive indicator for future bullish movement.
CANF Stock Price Chart
What is Can Fite Biofarma's stock price today?
-
The Can Fite Biofarma share price today is $1.48Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CANF is experiencing slight buying pressure.
TEVA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.89 | Buy |
Relative Strength Index (14 RSI): | 78.06 | Buy |
Chaikin Money Flow: | 10830015 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (16.04 - 19.36) | Buy |
Bollinger Bands (100): | (16.85 - 18.79) | Buy |
CANF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.18 | Sell |
Relative Strength Index (14 RSI): | 35.58 | Sell |
Chaikin Money Flow: | 104053 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.51 - 2.05) | Sell |
Bollinger Bands (100): | (1.82 - 2.58) | Sell |
TEVA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 19.09 | Buy |
20-day SMA: | 17.93 | Buy |
50-day SMA: | 17.79 | Buy |
200-day SMA: | 16.61 | Buy |
8-day EMA: | 19.83 | Buy |
20-day EMA: | 18.53 | Buy |
50-day EMA: | 17.93 | Buy |
200-day EMA: | 16.34 | Buy |
CANF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.5 | Sell |
20-day SMA: | 1.73 | Sell |
50-day SMA: | 2.07 | Sell |
200-day SMA: | 2.37 | Sell |
8-day EMA: | 1.5 | Sell |
20-day EMA: | 1.67 | Sell |
50-day EMA: | 1.93 | Sell |
200-day EMA: | 2.32 | Sell |
Teva Pharmaceutical Industries Earnings Growth & TEVA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.17 per share, and an increase next year of $0.33 per share.
Can Fite Biofarma Earnings Growth & CANF Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.20 per share, and a decrease next year of $0.10 per share.
Teva Pharmaceutical Industries Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Can Fite Biofarma Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |